Injection delivery system developer ApiJect announced that it promoted Molly Weaver to the position of chief operating ...

MannKind announced top-level 30-week results from its Phase 4 INHALE-3 study comparing inhaled insulin to traditional ...

Eyenovia (Nasdaq:EYEN) announced that it began manufacturing batches of its Mydcombi product for its next-generation delivery ...

Qnovia announced that the FDA cleared its investigational new drug (IND) application for the RespiRx smoking cessation ...

Ascensia Diabetes Care announced today that it launched the Eversense 365 CGM system from Senseonics (NYSE:SENS) ...

Stevanato Group announced today that it expanded the capacity of its Vertiva on-body device for subcutaneous large-volume ...

CereVasc shared data from a study demonstrating that its eShunt system may help deliver gene therapies to the central nervous ...

Vivani Medical today announced that Australian authorities approved a first-in-human clinical trial for its subdermal GLP-1 ...

PCI Pharma Services announced that it's investing more than $365 million in infrastructure to support assembly and packaging ...

Dexcom (Nasdaq:DXCM) today announced a collaboration to establish National Glucose Awareness Week from Sept. 23-29, 2024.

RenovoRx announced today that it plans to increase the production of its RenovoCath catheter-based delivery system.

Ypsomed reports positive outcomes from a randomized trial of its closed-loop insulin delivery technology during type 1 ...